Differences in wage earnings between psoriasis patients on biologics versus those on oral therapies: a population-based study in the United States
Introduction A critical gap exists in determining how various systemic treatments may differentially impact patients’ wage earnings. Methods We compared personal economic indicators (annual and hourly wages, weekly hours worked, and disability days) between psoriasis patients on biologic therapies v...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2021-05-01
|
| Series: | Journal of Dermatological Treatment |
| Subjects: | |
| Online Access: | http://dx.doi.org/10.1080/09546634.2019.1666966 |
| _version_ | 1797683605544108032 |
|---|---|
| author | Khoa Nguyen Nazanin Ehsani-Chimeh Nicole Salame April W. Armstrong |
| author_facet | Khoa Nguyen Nazanin Ehsani-Chimeh Nicole Salame April W. Armstrong |
| author_sort | Khoa Nguyen |
| collection | DOAJ |
| description | Introduction A critical gap exists in determining how various systemic treatments may differentially impact patients’ wage earnings. Methods We compared personal economic indicators (annual and hourly wages, weekly hours worked, and disability days) between psoriasis patients on biologic therapies versus those on oral medications. Using the 2003–2015 Medical Expenditure Panel Survey, we performed multivariate linear regression analyses to investigate the relationship between personal economic indicators and psoriasis treatment. Results The number of U.S. respondents with psoriasis who reported using biologic or oral therapies between 2003 and 2015 was 2,638,681 (weighted). The mean annual wage among patients on biologics ($52,141.34 [95% CI 40,976–63,306]) was significantly higher than that of patients on oral therapies ($33,584.87 [95% CI 27,687–39,483]) (p=.019). The mean weekly hours worked among patients on biologics (43.7 h [95% CI 40.01–47.47]) was significantly higher than that of patients on oral therapies (40.6 h [95% CI 39.66–41.59]) (p = .003). Hourly wage and disability days were not significantly different between the two groups. Conclusions Psoriasis patients on biologics earned higher annual wages compared to those on oral therapies, and this is primarily due to the increased number of work hours by those on biologic therapies. |
| first_indexed | 2024-03-12T00:18:04Z |
| format | Article |
| id | doaj.art-55bac7b9069648759a7c778a5ff33ab4 |
| institution | Directory Open Access Journal |
| issn | 0954-6634 1471-1753 |
| language | English |
| last_indexed | 2024-03-12T00:18:04Z |
| publishDate | 2021-05-01 |
| publisher | Taylor & Francis Group |
| record_format | Article |
| series | Journal of Dermatological Treatment |
| spelling | doaj.art-55bac7b9069648759a7c778a5ff33ab42023-09-15T14:23:03ZengTaylor & Francis GroupJournal of Dermatological Treatment0954-66341471-17532021-05-0132444044510.1080/09546634.2019.16669661666966Differences in wage earnings between psoriasis patients on biologics versus those on oral therapies: a population-based study in the United StatesKhoa Nguyen0Nazanin Ehsani-Chimeh1Nicole Salame2April W. Armstrong3University of Central Florida College of MedicineDepartment of Dermatology, University of Southern California Keck School of MedicineIrvine School of Medicine, University of CaliforniaDepartment of Dermatology, University of Southern California Keck School of MedicineIntroduction A critical gap exists in determining how various systemic treatments may differentially impact patients’ wage earnings. Methods We compared personal economic indicators (annual and hourly wages, weekly hours worked, and disability days) between psoriasis patients on biologic therapies versus those on oral medications. Using the 2003–2015 Medical Expenditure Panel Survey, we performed multivariate linear regression analyses to investigate the relationship between personal economic indicators and psoriasis treatment. Results The number of U.S. respondents with psoriasis who reported using biologic or oral therapies between 2003 and 2015 was 2,638,681 (weighted). The mean annual wage among patients on biologics ($52,141.34 [95% CI 40,976–63,306]) was significantly higher than that of patients on oral therapies ($33,584.87 [95% CI 27,687–39,483]) (p=.019). The mean weekly hours worked among patients on biologics (43.7 h [95% CI 40.01–47.47]) was significantly higher than that of patients on oral therapies (40.6 h [95% CI 39.66–41.59]) (p = .003). Hourly wage and disability days were not significantly different between the two groups. Conclusions Psoriasis patients on biologics earned higher annual wages compared to those on oral therapies, and this is primarily due to the increased number of work hours by those on biologic therapies.http://dx.doi.org/10.1080/09546634.2019.1666966annual wageswageswork hourspsoriasisbiologicsoral therapiesabsenteeismpresenteeism |
| spellingShingle | Khoa Nguyen Nazanin Ehsani-Chimeh Nicole Salame April W. Armstrong Differences in wage earnings between psoriasis patients on biologics versus those on oral therapies: a population-based study in the United States Journal of Dermatological Treatment annual wages wages work hours psoriasis biologics oral therapies absenteeism presenteeism |
| title | Differences in wage earnings between psoriasis patients on biologics versus those on oral therapies: a population-based study in the United States |
| title_full | Differences in wage earnings between psoriasis patients on biologics versus those on oral therapies: a population-based study in the United States |
| title_fullStr | Differences in wage earnings between psoriasis patients on biologics versus those on oral therapies: a population-based study in the United States |
| title_full_unstemmed | Differences in wage earnings between psoriasis patients on biologics versus those on oral therapies: a population-based study in the United States |
| title_short | Differences in wage earnings between psoriasis patients on biologics versus those on oral therapies: a population-based study in the United States |
| title_sort | differences in wage earnings between psoriasis patients on biologics versus those on oral therapies a population based study in the united states |
| topic | annual wages wages work hours psoriasis biologics oral therapies absenteeism presenteeism |
| url | http://dx.doi.org/10.1080/09546634.2019.1666966 |
| work_keys_str_mv | AT khoanguyen differencesinwageearningsbetweenpsoriasispatientsonbiologicsversusthoseonoraltherapiesapopulationbasedstudyintheunitedstates AT nazaninehsanichimeh differencesinwageearningsbetweenpsoriasispatientsonbiologicsversusthoseonoraltherapiesapopulationbasedstudyintheunitedstates AT nicolesalame differencesinwageearningsbetweenpsoriasispatientsonbiologicsversusthoseonoraltherapiesapopulationbasedstudyintheunitedstates AT aprilwarmstrong differencesinwageearningsbetweenpsoriasispatientsonbiologicsversusthoseonoraltherapiesapopulationbasedstudyintheunitedstates |